Literature DB >> 12690289

Bone marrow homing: the players, the playfield, and their evolving roles.

Thalia Papayannopoulou1.   

Abstract

Although homing of hematopoietic cells to the bone marrow was described as a functional concept several decades ago, the analysis of its components and the molecular pathways involved remains an ongoing challenge. Because of the biologic and clinical significance of homing, a resurgence of studies delving into the mechanistic and molecular aspects of homing is appearing. These recent studies, highlighted in this brief review, emphasize newly appreciated roles of some known regulators and their interacting partners in homing, although some novel regulators also seem to enter the scene. The homing field still has disparities in experimental design and evaluation of data; however, the ever-expanding search for new information, together with the application of novel technologies, especially when combinations of approaches are used, will certainly bring our understanding of homing to a new level.

Mesh:

Substances:

Year:  2003        PMID: 12690289     DOI: 10.1097/00062752-200305000-00004

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  30 in total

Review 1.  Unchain my heart: the scientific foundations of cardiac repair.

Authors:  Stefanie Dimmeler; Andreas M Zeiher; Michael D Schneider
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines.

Authors:  Halvard Bonig; Gregory V Priestley; Thalia Papayannopoulou
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

Review 3.  Hematopoietic stem and progenitor cells: their mobilization and homing to bone marrow and peripheral tissue.

Authors:  Christian Schulz; Ulrich H von Andrian; Steffen Massberg
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  G-CSF enhanced SDF-1 gradient between bone marrow and liver associated with mobilization of peripheral blood CD34+ cells in rats with acute liver failure.

Authors:  Yan Lei; Zhengwen Liu; Qunying Han; Wen Kang; Lei Zhang; Sai Lou
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

5.  Congenic interval of CD45/Ly-5 congenic mice contains multiple genes that may influence hematopoietic stem cell engraftment.

Authors:  Amanda Waterstrat; Ying Liang; Carol F Swiderski; Brent J Shelton; Gary Van Zant
Journal:  Blood       Date:  2009-11-09       Impact factor: 22.113

6.  Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.

Authors:  Anna Rita Migliaccio; Fabrizio Martelli; Maria Verrucci; Giovanni Migliaccio; Alessandro Maria Vannucchi; Hongyu Ni; Mingjiang Xu; Yi Jiang; Betty Nakamoto; Thalia Papayannopoulou; Ronald Hoffman
Journal:  Exp Hematol       Date:  2008-02       Impact factor: 3.084

7.  Cellular therapy for repair of cardiac damage after acute myocardial infarction.

Authors:  Matthew M Cook; Katarina Kollar; Gary P Brooke; Kerry Atkinson
Journal:  Int J Cell Biol       Date:  2009-03-29

8.  Noninvasive tracking of donor cell homing by near-infrared fluorescence imaging shortly after bone marrow transplantation.

Authors:  Takashi Ushiki; Shinae Kizaka-Kondoh; Eishi Ashihara; Shotaro Tanaka; Masayoshi Masuko; Hideyo Hirai; Shinya Kimura; Yoshifusa Aizawa; Taira Maekawa; Masahiro Hiraoka
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

9.  Defective engraftment of C3aR-/- hematopoietic stem progenitor cells shows a novel role of the C3a-C3aR axis in bone marrow homing.

Authors:  M Wysoczynski; R Reca; H Lee; W Wu; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2009-04-09       Impact factor: 11.528

10.  Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells.

Authors:  E Camilla Forsberg; Emmanuelle Passegué; Susan S Prohaska; Amy J Wagers; Martina Koeva; Joshua M Stuart; Irving L Weissman
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.